SuPA Mobility: Supporting Physical Activity for Mobility in Mobility-Limited Older Adults

Not Applicable

Recruiting

• Conditions: Limitation, Mobility; Older Adults

• Registration Number: NCT05978336
• Lead Sponsor: University of British Columbia

Brief Summary

The goal of this randomized controlled trial is to investigate the effectiveness of a health-coaching intervention to improve physical activity in older adults with limited mobility when compared to a control, health education group.

Detailed Description

A total of 290 older adults with limited mobility will be randomized to either a 26-week health coaching program or health education program. Outcomes will be assessed at baseline, 13-weeks, 26-weeks (end of intervention), and 52 week (6-month follow-up period).

Study Timeline

• Study First Submitted: 2023-07-28
• Study First Submitted QC: 2023-07-28
• Study First Posted: 2023-08-07
• Study Start: 2023-09-05
• Status Verified: 2024-12
• Last Update Submitted: 2024-12-03
• Last Update Posted: 2024-12-04
• Primary Completion: 2027-06-30
• Study Completion: 2027-12-30

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 290

Inclusion Criteria

• scored ≤ 9/12 on the SPPB
• are able to complete the 400-m walk in ≤ 15 minutes without sitting or physical assistance from another person or walker (use of cane is acceptable)
• scored 22/30 or higher on the Mini-Mental State Examination (MMSE)
• have no significant functional impairment as indicated by a score of 6/8 or higher on the Lawton and Brody Instrumental Activities of Daily Living Scale
• are able to safely engage in MVPA as indicated by the PAR-Q+ and by the family or study physician as necessary
• are community-dwelling
• are able to provide written informed consent.

Exclusion Criteria

• are diagnosed with dementia or stroke
• self-report engaging in MVPA ≥ 10 minutes per week in the prior 3 months
• are unable to understand, speak, and read English proficiently

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Mobility	Baseline, 13-weeks, 26-weeks, 52-weeks	Measured by the Short Physical Performance Battery (SPPB)

Secondary Outcome Measures

Name	Time	Method
Gait speed	Baseline, 13- weeks, 26-weeks, 52-weeks	Measured during the 4-m walk
Lower extremity strength	Baseline, 13- weeks, 26-weeks, 52-weeks	Measured with strain gauge (kilograms) on dominant quadriceps
Sleep	Baseline, 13-weeks, 26-weeks, 52-weeks	Measured by accelerometer
Falls	Baseline, monthly	Assessed with monthly calendar and questionnaire
Grip strength	Baseline, 13-weeks, 26-weeks, 52-weeks	Measured with digital Jamar isometric dynamometer (Newtons)
Health resource utilization	Baseline, 13-weeks, 26-weeks, 39-weeks, 52-weeks	Assessed with a questionnaire
Functional mobility	Baseline, 13-weeks, 26-weeks, 39-weeks, 52-weeks	Measured as the time to complete the Timed Up-and-Go (TUG)
Mood	Baseline, 13-weeks, 26-weeks, 39-weeks, 52-weeks	Measured by the Centre for Epidemiological Studies Depression Scale (CES-D)
Health-related quality of life	Baseline, 13-weeks, 26-weeks, 39-weeks, 52-weeks	Measured with questionnaire EuroQol (EQ-5D-5L)
Physical activity	Baseline, 13-weeks, 26-weeks, 52-weeks	Time spent moderate to vigorous physical activity and sedentary time measured by accelerometer.
Self reported physical activity	Baseline, 13-weeks, 26-weeks, 52-weeks	Measured by the Community Health Activities Model Program for Seniors (CHAMPS) Physical Activity Questionnaire for Older Adults.
Fatigue	Baseline, 13-weeks, 26-weeks, 39-weeks, 52-weeks	Measured by the 9-item Fatigue Severity Scale (FSS) scored from 9 to 63, with higher scores indicating more severe fatigue
Capacity to complete the 400-m walk in ≤ 15 minutes	Baseline, 13- weeks, 26-weeks, 52-weeks	measured as yes or no
Cognitive function	Baseline, 26-weeks, 52-weeks	Measured with the NIH Toolbox and standard neuropsychological assessments
Community mobility	Baseline, 13-weeks, 26-weeks, 39-weeks, 52-weeks	Measured with the Life Space Questionnaire

Trial Locations

Locations (1)

Vancouver Coastal Health Research Institute Research Pavilion; 🇨🇦 Vancouver, British Columbia, Canada